170 related articles for article (PubMed ID: 16164754)
1. Efficiency of an inexpensive liquid-based cytology performed by cytocentrifugations: a comparative study using the histology as reference standard.
Garbar C; Mascaux C; Fontaine V
Cytojournal; 2005 Sep; 2():15. PubMed ID: 16164754
[TBL] [Abstract][Full Text] [Related]
2. A Shandon PapSpin liquid-based gynecological test: A split-sample and direct-to-vial test with histology follow-up study.
Rimiene J; Petronyte J; Gudleviciene Z; Smailyte G; Krasauskaite I; Laurinavicius A
Cytojournal; 2010 Mar; 7():2. PubMed ID: 20376176
[TBL] [Abstract][Full Text] [Related]
3. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
4. [Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].
Ronco G; Confortini M; Maccallini V; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Giorgi Rossi P
Epidemiol Prev; 2012; 36(5 Suppl 2):e1-e33. PubMed ID: 23139163
[TBL] [Abstract][Full Text] [Related]
5. Twelve-month follow-up detection of high-risk human papillomavirus (HPV) DNA for 93 cases with cervical intraepithelial neoplasia grade 2 or 3 (CIN 2-3) after a loop electrosurgical excisional procedure (LEEP).
Guo HY; Guo YL; You K; Geng L
Eur J Gynaecol Oncol; 2011; 32(2):164-7. PubMed ID: 21614905
[TBL] [Abstract][Full Text] [Related]
6. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL
Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ThinPrep and SurePath liquid-based cytology and subsequent human papillomavirus DNA testing in China.
Zhao FH; Hu SY; Bian JJ; Liu B; Peck RB; Bao YP; Pan QJ; Frappart L; Sellors J; Qiao YL
Cancer Cytopathol; 2011 Dec; 119(6):387-94. PubMed ID: 21774094
[TBL] [Abstract][Full Text] [Related]
8. Is a liquid-based cytology more sensitive than a conventional Pap smear?
Sigurdsson K
Cytopathology; 2013 Aug; 24(4):254-63. PubMed ID: 23331613
[TBL] [Abstract][Full Text] [Related]
9. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer screening by molecular Pap-transformation of gynecologic cytology.
Barodawala SM; Chadha K; Kavishwar V; Murthy A; Shetye S
Diagn Cytopathol; 2019 May; 47(5):374-381. PubMed ID: 30468313
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Performance of the Newly Developed WellPrep® Liquid-Based Cytology System and Its Comparison with SurePathTM in Cervical Squamous Lesions.
Choi JE; Jin MS; Nikas IP; Ryu HS
Acta Cytol; 2023; 67(1):27-37. PubMed ID: 36412571
[TBL] [Abstract][Full Text] [Related]
12. Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear.
Monsonego J; Bohbot JM; Pollini G; Krawec C; Vincent C; Merignargues I; Haroun F; Sednaoui P; Monfort L; Dachez R; Syrjänen K
Gynecol Oncol; 2005 Oct; 99(1):160-8. PubMed ID: 16023184
[TBL] [Abstract][Full Text] [Related]
13. Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force.
Whitlock EP; Vesco KK; Eder M; Lin JS; Senger CA; Burda BU
Ann Intern Med; 2011 Nov; 155(10):687-97, W214-5. PubMed ID: 22006930
[TBL] [Abstract][Full Text] [Related]
14. Comparison between Siriraj liquid-based and conventional cytology for detection of abnormal cervicovaginal smears: a split-sample study.
Laiwejpithaya S; Rattanachaiyanont M; Benjapibal M; Khuakoonratt N; Boriboonhirunsarn D; Laiwejpithaya S; Sangkarat S; Wongtiraporn W
Asian Pac J Cancer Prev; 2008; 9(4):575-80. PubMed ID: 19256741
[TBL] [Abstract][Full Text] [Related]
15. Cervical Cancer Screening: Comparison of Conventional Pap Smear Test, Liquid-Based Cytology, and Human Papillomavirus Testing as Stand-alone or Cotesting Strategies.
Liang LA; Einzmann T; Franzen A; Schwarzer K; Schauberger G; Schriefer D; Radde K; Zeissig SR; Ikenberg H; Meijer CJLM; Kirkpatrick CJ; Kölbl H; Blettner M; Klug SJ
Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):474-484. PubMed ID: 33187968
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of conventional cytology and a low-cost liquid-based cytology technique, EziPREP™, for cervicovaginal smear reporting: A split sample study.
Gupta R; Yadav R; Sharda A; Kumar D; Sandeep ; Mehrotra R; Gupta S
Cytojournal; 2019; 16():22. PubMed ID: 31803248
[TBL] [Abstract][Full Text] [Related]
17. Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico.
Torres-Ibarra L; Cuzick J; Lorincz AT; Spiegelman D; Lazcano-Ponce E; Franco EL; Moscicki AB; Mahmud SM; Wheeler CM; Rivera-Paredez B; Hernández-López R; León-Maldonado L; Salmerón J;
JAMA Netw Open; 2019 Nov; 2(11):e1915781. PubMed ID: 31747033
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the Performance of p16
Song F; Du H; Xiao A; Wang C; Huang X; Yan P; Liu Z; Qu X; Belinson JL; Wu R
Cancer Manag Res; 2020; 12():9067-9075. PubMed ID: 33061601
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of artificial intelligence-assisted liquid-based cytology testing for cervical cancer screening in China.
Shen M; Zou Z; Bao H; Fairley CK; Canfell K; Ong JJ; Hocking J; Chow EPF; Zhuang G; Wang L; Zhang L
Lancet Reg Health West Pac; 2023 May; 34():100726. PubMed ID: 37283979
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of screening performance between primary high-risk HPV screening and high-risk HPV screening plus liquid-based cytology cotesting in diagnosis of cervical precancerous or cancerous lesions].
Zhao XL; Remila R; Hu SY; Zhang L; Xu XQ; Chen F; Pan QJ; Zhang X; Zhao FH
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 May; 52(5):469-474. PubMed ID: 29747337
[No Abstract] [Full Text] [Related]
[Next] [New Search]
